Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, February 05, 2021 at 01:00 p.m. IST for discussing the un-audited financial results of the Company for the quarter ended December 2020. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is the copy of Press Release titled 'LASA SUPERGENERICS Q3FY21 PAT AT 6.56 CRS UP BY 154% YoY Finance Cost Reduced by 95.40% YoY. ' issued by the company. Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. February 01, 2021
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today commenced at 10.30 a.m. and concluded at 12:30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter ended December 31 2020. A copy of the statement of Unaudited Financial Results along with Limited Review Report submitted by the Statutory Auditors of the Company is attached herewith. Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E. February 01, 2021
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today commenced at 10.30 a.m. and concluded at 12:30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter ended December 31 2020 Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Unaudited Financial Results Along With The Limited Review Report Of The Company For The Quarter Ended December 30, 2020
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of The Board of Director of the Company is scheduled to be held on Monday February 01, 2021 to consider, approve and take on record Unaudited Financial Results along with the Limited Review Report of the Company for the quarter ended December 30, 2020, and/or to discuss any other business/matter with the permission of the Chairman. Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended December 31, 2020
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company. Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi KulshtresthaDesignation :- Company Secretary and Compliance Officer Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached is the copy of Press Release titled ' LASA SUPERGENERICS RECEIVED WHO Nod for its unit Located at Khed (Ratnagiri). ' issued by the company. Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. January 01, 2021 till 48 hours after the declaration of financial results (both days inclusive) for the quarter ended December 31, 2020